Home › Funds › Redmile Group, LLC › NUVB
Redmile Group, LLC position in NUVB
NUVATION BIO INC · Health Care
Redmile Group, LLC reported holding 3,031,009 shares of NUVB (NUVATION BIO INC) in its Q2 2026 13F filing — a position valued at US$17.2M, representing 1.16% of its reported portfolio and ranking #18 among its reported holdings. Redmile Group, LLC has disclosed NUVB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's NUVB position evolved
Redmile Group, LLC first disclosed a stake in NUVB in Q3 2023 at 3,031,009 shares (US$4.1M). The position peaked in Q4 2025 at 3,163,256 shares, worth US$28.3M. Across 12 filings, Redmile Group, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 3,031,009 shares valued at US$17.2M — a reduction of -122,247 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.03M | $4.06M | New |
| Q4 2023 | 3.03M | $4.58M | Hold |
| Q1 2024 | 3.03M | $11.03M | Hold |
| Q2 2024 | 3.03M | $8.85M | Hold |
| Q3 2024 | 3.03M | $6.94M | Hold |
| Q4 2024 | 3.03M | $8.06M | Hold |
| Q1 2025 | 3.03M | $5.33M | Hold |
| Q2 2025 | 3.03M | $5.91M | Hold |
| Q3 2025 | 3.03M | $11.21M | Hold |
| Q4 2025 | 3.16M | $28.34M | Add |
| Q1 2026 | 3.15M | $13.53M | Hold |
| Q2 2026 | 3.03M | $17.22M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 53 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M sh · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M sh · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
- TANAKA CAPITAL MANAGEMENT INC 901.83K sh · $3.87M · Q1 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held NUVB?
Redmile Group, LLC has disclosed NUVB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in NUVB?
As of Q2 2026, Redmile Group, LLC holds 3.03M shares of NUVB (NUVATION BIO INC), valued at $17.22M, representing 1.16% of its reported portfolio and ranking #18.
Has Redmile Group, LLC been buying or selling NUVB?
In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in NUVB. The position peaked in Q4 2025 at 3.16M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.